Progress Without Closure

This flow develops the theme that scientific progress changes the shape of uncertainty rather than eliminating it.

increasingBearing stren­gth in each eventdecreasing

First Standards

First Standards Limited treatment Interferon-based therapy offers partial viral control, while dialysis transmission remains common and transplant policy is cautious. Medicine works with incomplete diagnostics and imperfect tools. Hope under constraint The early period is not defined by failure alone. It establishes the methods, cohorts, and questions that later progress will depend upon.

Guideline Consolidation

Guideline Consolidation Knowledge organized KDIGO recommendations connect screening, renal evaluation, dialysis prevention, antiviral therapy, and transplantation. The field gains a common structure. Questions remain The guideline cannot resolve every dosing issue, posttransplant treatment risk, or donor allocation dilemma. Organization of knowledge reveals the boundaries of knowledge.

Next-Generation Promise

Next-Generation Promise Oral antiviral future Direct-acting antiviral drugs promise higher response rates and shorter, more tolerable regimens. Their arrival suggests that many previous compromises may eventually become avoidable. Unfinished translation Patients with renal failure and transplant recipients remain underrepresented in available evidence. Progress reaches the edge of the population that most needs tailored data.

1990s

2008

2011 to 2012